Treatment of in-transit metastases from merkel cell carcinoma with isolated hyperthermic limb infusion [1]

American Surgeon

Volumn 74, Issue 12, 2008, Pages 1222-1223

  Grobmyer, Stephen R ^a   Copeland III, Edward M ^a   Hochwald, Steven N ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; MELPHALAN;

CANCER CHEMOTHERAPY; CANCER SURGERY; CATHETERIZATION; DRUG INFUSION; EXCISION; HUMAN; HYPERTHERMIC LIMB INFUSION; IN-TRANSIT METASTASIS; LETTER; LIMB PERFUSION; MERKEL CELL TUMOR; MINIMALLY INVASIVE PROCEDURE; MORBIDITY; OPERATION DURATION;

AGED; CARCINOMA, MERKEL CELL; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; HUMANS; HYPERTHERMIA, INDUCED; LEG; MALE; SKIN NEOPLASMS;

EID: 57449107830     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Wood BC, Kleinpeter KP, Levine EA. Treatment of in-transit metastases from Merkel cell carcinoma with isolated hyperthermic limb perfusion. Am Surg 2007;73:1291-2.
2. Gupta AS, Heinzman S, Levine EA. Successful treatment of in-transit metastases from Merkel's cell carcinoma with isolated hyperthermic limb perfusion. South Med J 1998;91:289-92.
3. Bichakjian CK, Lowe L, Lao C, et al. Merkel cell carcinoma: Critical review with management guidelines for multidisciplinary management. Cancer 2007;110:1-12.
4. Thompson JF, Kam PC, Waugh RC, Harman CR. Isolated limb infusion with cytotoxic agents: A simple alternative to isolated limb perfusion. Semin Surg Oncol 1998;14:238-47.
5. Linder P, Doubrovsky A, Kam PC, Thompson JF. Prognostic factors after isolated limb infusion with cytotoxic agents for melanoma. Ann Surg Oncol 2002;9:127-36.
6. Thompson JF, Siebert GA, Anissimov YG, et al. Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignancies. Br J Cancer 2001;85:157-65.